Literature DB >> 9272610

Glucose: a continuous risk factor for cardiovascular disease.

H C Gerstein1.   

Abstract

The glucose level that defines diabetes mellitus is that level above which patients have a high risk of eye, kidney, and neuronal disease. The risk of these complications rises as glucose levels increase, and decreases as therapy brings the glucose level down. Thus, in patients with diabetes, glucose is a continuous, modifiable risk factor for eye, kidney and peripheral nerve disease. Plasma glucose concentrations in the diabetic range are also a continuous risk factor for cardiovascular disease (CVD). Moreover, epidemiological evidence shows that the relationship between plasma glucose concentration and CVD extends well below the glucose level defined for diabetes and even impaired glucose tolerance. This continuous relationship between glucose and CVD exists in all people, not just in those with a defined metabolic disease, and is therefore similar to the relationship between cholesterol or blood pressure and CVD. It may be secondary to either a direct effect of elevated glucose or to some underlying metabolic abnormality that raises both glucose and cardiovascular risk. Whether interventions that lower glucose will also lower the risk of CVD is still unknown; the results of clinical trials are awaited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9272610     DOI: 10.1002/(sici)1096-9136(199708)14:3+<s25::aid-dia441>3.3.co;2-t

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

Review 1.  The postprandial effects of dietary antioxidants in humans.

Authors:  Colin D Kay; Bruce J Holub
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 2.  Effect of long-term growth hormone replacement on glucose metabolism in adults with growth hormone deficiency: a systematic review and meta-analysis.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Yingxuan Wang; Guixia Wang
Journal:  Pituitary       Date:  2021-02       Impact factor: 4.107

3.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

4.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).

Authors:  K T Khaw; N Wareham; R Luben; S Bingham; S Oakes; A Welch; N Day
Journal:  BMJ       Date:  2001-01-06

5.  [Early determinants of random blood glucose among adults of the 1982 birth cohort, Pelotas, Southern Brazil].

Authors:  Bernardo L Horta; Denise P Gigante; Cesar G Victora; Fernando C Barros; Isabel Oliveira; Vera Silveira
Journal:  Rev Saude Publica       Date:  2008-12       Impact factor: 2.106

6.  Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load.

Authors:  Lauren K Walsh; Robert M Restaino; Martha Neuringer; Camila Manrique; Jaume Padilla
Journal:  Clin Sci (Lond)       Date:  2016-08-08       Impact factor: 6.124

7.  Air Pollution and Serum Glucose Levels: A Population-Based Study.

Authors:  Maayan Yitshak Sade; Itai Kloog; Idit F Liberty; Itzhak Katra; Lena Novack; Victor Novack
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.

Authors:  Matti Uusitupa; Markku Peltonen; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Timo T Valle; Johan G Eriksson; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

Review 9.  HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?

Authors:  Bernd Kowall; Wolfgang Rathmann
Journal:  Diabetes Metab Syndr Obes       Date:  2013-11-29       Impact factor: 3.168

Review 10.  Regulation of extracellular signal-regulated kinase 1/2 influences hippocampal neuronal survival in a rat model of diabetic cerebral ischemia.

Authors:  Yaning Zhao; Jianmin Li; Qiqun Tang; Pan Zhang; Liwei Jing; Changxiang Chen; Shuxing Li
Journal:  Neural Regen Res       Date:  2014-04-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.